Autophagy flux inhibition augments gastric cancer resistance to the anti-human epidermal growth factor receptor 2 antibody trastuzumab.

about

Autophagy flux inhibition augments gastric cancer resistance to the anti-human epidermal growth factor receptor 2 antibody trastuzumab.

Item

http://www.wikidata.org/entity/Q53701966

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Autophagy flux inhibition augm ...... ceptor 2 antibody trastuzumab.

@en

Autophagy flux inhibition augm ...... ceptor 2 antibody trastuzumab.

@nl

type

Item

label

Autophagy flux inhibition augm ...... ceptor 2 antibody trastuzumab.

@en

Autophagy flux inhibition augm ...... ceptor 2 antibody trastuzumab.

@nl

prefLabel

Autophagy flux inhibition augm ...... ceptor 2 antibody trastuzumab.

@en

Autophagy flux inhibition augm ...... ceptor 2 antibody trastuzumab.

@nl

P1476

Autophagy flux inhibition augm ...... ceptor 2 antibody trastuzumab.

@en

P2093

Cheng Zheng

http://www.w3.org/2001/XMLSchema#string

Dingcheng Zheng

http://www.w3.org/2001/XMLSchema#string

Feng Wu

http://www.w3.org/2001/XMLSchema#string

Hua Ye

http://www.w3.org/2001/XMLSchema#string

Ping Chen

http://www.w3.org/2001/XMLSchema#string

Qi Zheng

http://www.w3.org/2001/XMLSchema#string

Xiaoyu Wang

http://www.w3.org/2001/XMLSchema#string

Xuyu Chai

http://www.w3.org/2001/XMLSchema#string

P2860

HER2 testing in gastric cancer: An update

Chloroquine and hydroxychloroquine for cancer therapy

Autophagy in cancer

Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

Gemcitabine resistance in breast cancer cells regulated by PI3K/AKT-mediated cellular proliferation exerts negative feedback via the MEK/MAPK and mTOR pathways.

p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects.

Guttiferone K induces autophagy and sensitizes cancer cells to nutrient stress-induced cell death.

P304

4143-4150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.7891

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29541179

http://www.w3.org/2001/XMLSchema#string

P932

5835962

http://www.w3.org/2001/XMLSchema#string